Gene Mutation Provides Resistance to HIV Infection

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 9
Volume 5
Issue 9

NEW YORK--Scientists at the Aaron Diamond AIDS Research Center appear to have solved one of the long-standing enigmas of HIV infection--why some people remain uninfected even after repeated exposures to the virus. The answer lies in the genes, and in basic research published only a few months earlier.

NEW YORK--Scientists at the Aaron Diamond AIDS Research Centerappear to have solved one of the long-standing enigmas of HIVinfection--why some people remain uninfected even after repeatedexposures to the virus. The answer lies in the genes, and in basicresearch published only a few months earlier.

Studies of two homosexual men who have avoided infection sincethe start of the AIDS epidemic, despite having HIV-positive partners,uncovered a genetic mutation that appears to protect against infectionwith the virus. Both men were found to have two mutant copiesof the CCR5 gene (also known as CKR-5, or chemokine receptor-5),whose discovery was reported by five different groups in Junein a flurry of papers in Nature, Science, and Cell.

The CCR5 gene produces a protein receptor that allows HIV entryinto human immune cells. The two men with the mutant gene didnot have the receptor, Dr. Nathan R. Landau and his colleaguesreported in the journal Cell (August 9, 1996).

Other work suggests that as many as 1% of whites of Western Europeandescent may have the gene mutation, and up to 20% of whites mayhave one copy of the defective gene. Even one copy may have aprotective role, either in lowering the risk of infection or indelaying progression of HIV after infection.

Recent Videos
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content